Are you looking to add some shares to your portfolio next week?
If you are, three ASX 200 shares that could be worth considering are listed below. Here's why analysts are tipping them as buys:
Altium Limited (ASX: ALU)
The first ASX 200 share for investors to consider is Altium. It is a leading printed circuit board (PCB) design software provider. This is a great place to be because there has been an explosion in electronic devices globally thanks to the Internet of Things and artificial intelligence booms. And as PCBs are the boards you find inside almost all electronic devices and are integral to their operation, this bodes well for demand for Altium's offering. Management certainly believes this to be the case. It is very confident in the company's outlook and is aiming to more than double its revenue to US$500 million by 2026.
Jefferies is positive on the company. It currently has a buy rating and $38.13 price target on its shares.
Cochlear Limited (ASX: COH)
Another ASX 200 share that could be a buy is Cochlear. It is one of the world's leading hearing solutions companies and has been growing at a solid rate for many years. This has been driven by its portfolio of world class products, which have been developed thanks to its significant annual investment in research and development. Looking ahead, Cochlear appears well-placed for long term growth due to its strong position in a market benefiting from tailwinds such as ageing populations.
Goldman Sachs is bullish on Cochlear. Its analysts currently have a buy rating and $247.00 price target on its shares.
Webjet Limited (ASX: WEB)
A final ASX 200 share that has been named as a buy is online travel agent Webjet. After a very difficult time during the pandemic, Webjet is now back on form thanks to rebounding travel markets. And with its costs reduced materially from pre-pandemic levels, the company looks set to be a much more efficient business in the future. This bodes well for its growth in the coming years.
Goldman Sachs is also very positive on Webjet. Its analysts currently have a buy rating and $6.80 price target on its shares.
